These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1367 related articles for article (PubMed ID: 8652455)

  • 1. Prevention and management of complications associated with the hydroxyapatite implant.
    Kaltreider SA; Newman SA
    Ophthalmic Plast Reconstr Surg; 1996 Mar; 12(1):18-31. PubMed ID: 8652455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of exposed hydroxyapatite orbital implants.
    Kim YD; Goldberg RA; Shorr N; Steinsapir KD
    Ophthalmology; 1994 Oct; 101(10):1709-15. PubMed ID: 7936570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of natural hydroxyapatite implants covered with Vicryl® mesh in a series of 704 enucleations].
    Ricaud X; Levy-Gabriel C; Lumbroso-Le Rouic L; Cassoux N; Esteve M; Plancher C; Asselain B; Desjardins L
    J Fr Ophtalmol; 2014 Feb; 37(2):99-106. PubMed ID: 24210936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.
    Shields CL; Shields JA; De Potter P; Singh AD
    Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma.
    Heimann H; Bechrakis NE; Zepeda LC; Coupland SE; Hellmich M; Foerster MH
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):123-8. PubMed ID: 15778666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyapatite orbital implant after enucleation--experience with 200 cases.
    Shields JA; Shields CL; De Potter P
    Mayo Clin Proc; 1993 Dec; 68(12):1191-5. PubMed ID: 8246621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants.
    Arat YO; Shetlar DJ; Boniuk M
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):189-93. PubMed ID: 12918552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
    Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
    Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyapatite orbital implants. Experience with 100 cases.
    McNab A
    Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the hydroxyapatite ocular implant in the pediatric population.
    De Potter P; Shields CL; Shields JA; Singh AD
    Arch Ophthalmol; 1994 Feb; 112(2):208-12. PubMed ID: 8311774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
    Lee V; Subak-Sharpe I; Hungerford JL; Davies NP; Logani S
    Ophthalmology; 2000 May; 107(5):940-5; discussion 946. PubMed ID: 10811087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos.
    Massry GG; Holds JB
    Ophthalmology; 1995 Jan; 102(1):161-6. PubMed ID: 7831032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study of the hydroxyapatite orbital implant.
    Ashworth JL; Rhatigan M; Brammar R; Sunderland S; Leatherbarrow B
    Eur J Ophthalmol; 1997; 7(1):1-8. PubMed ID: 9101187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients.
    Shields CL; Uysal Y; Marr BP; Lally SE; Rodriques E; Kharod B; Shields JA
    Ophthalmology; 2007 Feb; 114(2):367-73. PubMed ID: 17270685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue breakdown and exposure associated with orbital hydroxyapatite implants.
    Buettner H; Bartley GB
    Am J Ophthalmol; 1992 Jun; 113(6):669-73. PubMed ID: 1317993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enucleation technique for children with retinoblastoma.
    Shields JA; Shields CL; De Potter P
    J Pediatr Ophthalmol Strabismus; 1992; 29(4):213-5. PubMed ID: 1324985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants.
    Colen TP; Paridaens DA; Lemij HG; Mourits MP; van Den Bosch WA
    Ophthalmology; 2000 Oct; 107(10):1889-94. PubMed ID: 11013194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.